Laurent Loufrani Selected Research

Hemolysis

6/2015

Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laurent Loufrani Research Topics

Disease

9	Hypertension (High Blood Pressure) 01/2021 - 07/2002
4	Inflammation (Inflammations) 01/2020 - 08/2011
4	Ischemia 01/2019 - 07/2002
4	Muscular Diseases (Myopathy) 10/2005 - 01/2002
3	Diabetes Mellitus 01/2017 - 02/2010
2	Atherosclerotic Plaque (Atheroma) 11/2021 - 01/2018
2	Hypertrophy 01/2021 - 01/2010
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2018 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 03/2014 - 06/2012
1	Abdominal Aortic Aneurysm 06/2022
1	Aortic Aneurysm (Aneurysm, Aortic) 06/2022
1	Hyperlipidemias (Hyperlipidemia) 06/2022
1	Aneurysm (Aneurysms) 06/2022
1	Atherosclerosis 05/2022
1	Autoimmune Diseases (Autoimmune Disease) 09/2020
1	Hyperplasia 02/2020
1	Hyperemia 01/2019
1	Vascular Remodeling 01/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2017
1	Wounds and Injuries (Trauma) 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Sickle Cell Anemia (Hemoglobin S Disease) 06/2015
1	Vascular System Injuries 06/2015
1	Hemolysis 06/2015
1	Reperfusion Injury 01/2011
1	Insulin Resistance 01/2011
1	Hemorrhagic Shock 01/2010
1	Acidosis 01/2010
1	Shock 01/2010
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2010
1	Hemorrhage 01/2010
1	Autosomal Dominant Polycystic Kidney (ADPKD) 10/2009
1	Renal Insufficiency (Renal Failure) 10/2009

Drug/Important Bio-Agent (IBA)

5	Angiotensin IIIBA 06/2022 - 01/2010
4	Vasodilator Agents (Vasodilators)IBA 01/2017 - 07/2002
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2008
3	DystrophinIBA 10/2005 - 12/2002
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2022 - 08/2011
2	Superoxides (Superoxide)IBA 05/2022 - 01/2010
2	Estrogens (Estrogen)FDA Link 11/2021 - 01/2018
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2021 - 01/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 11/2011
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2021 - 01/2010
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2018 - 01/2018
2	Vasoconstrictor AgentsIBA 01/2018 - 01/2010
2	Type 2 Angiotensin ReceptorIBA 01/2017 - 03/2005
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2017 - 02/2010
2	AntioxidantsIBA 01/2017 - 03/2014
2	Streptozocin (Streptozotocin)FDA Link 01/2017 - 01/2011
2	Type 1 Angiotensin ReceptorIBA 01/2017 - 01/2010
2	alagebriumIBA 03/2014 - 06/2012
2	Monomeric GTP-Binding ProteinsIBA 02/2010 - 05/2008
2	DesminIBA 10/2002 - 01/2002
1	CholesterolIBA 06/2022
1	Glutamine (L-Glutamine)FDA Link 06/2022
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 06/2022
1	LipidsIBA 06/2022
1	Amino Acids FDA Link 06/2022
1	Carnitine (L-Carnitine)FDA LinkGeneric 06/2022
1	Taurine FDA Link 06/2022
1	Estrogen Receptor alphaIBA 11/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	Azathioprine (Imuran)FDA LinkGeneric 09/2020
1	SolutionsIBA 02/2020
1	Estrogen ReceptorsIBA 01/2020
1	Urea (Carbamide)FDA LinkGeneric 01/2020
1	CreatinineIBA 01/2020
1	pro-corticotropin releasing hormoneIBA 01/2019
1	AntibodiesIBA 01/2018
1	EstetrolIBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	neutrophil cytosol factor 67KIBA 01/2017
1	NucleotidesIBA 01/2016
1	UracilIBA 01/2016
1	purinoceptor P2Y6IBA 01/2016
1	Heme (Haem)IBA 06/2015
1	Hemoglobins (Hemoglobin)IBA 06/2015
1	Oxidants (Oxidizing Agents)IBA 06/2015
1	tempolIBA 03/2014
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2011
1	Heme Oxygenase-1IBA 08/2011
1	Erythropoietin FDA Link 01/2011
1	Phosphotransferases (Kinase)IBA 01/2011
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 07/2010
1	AldosteroneIBA 07/2010
1	Rho Guanine Nucleotide Exchange FactorsIBA 02/2010
1	sodium bisulfide (NaHS)IBA 01/2010
1	Perindopril FDA LinkGeneric 01/2010
1	ProstaglandinsIBA 01/2010
1	U 0126 (UO 126)IBA 01/2010
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2010
1	Mitogen-Activated Protein Kinase 3IBA 01/2010
1	candesartanIBA 01/2010
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2010
1	TRPP Cation ChannelsIBA 10/2009
1	TeaIBA 11/2007

Therapy/Procedure

1	Secondary Prevention 12/2018
1	Ligation 01/2018
1	Resuscitation 01/2010